<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Kuznar, Wayne</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Zile, Michael</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">BAT Improves Clinical Status Preferentially in Patients Not Undergoing CRT</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-07-02 10:57:42</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">12-12</style></pages><abstract><style  face="normal" font="default" size="100%">Baroreceptor activation therapy improves quality of life, exercise capacity, and potentially the burden of heart failure hospitalizations in patients with functional class III heart failure with reduced ejection fraction who are on optimal medical and/or device therapy, with pronounced benefit in patients who are not treated with cardiac resynchronization therapy.</style></abstract><number><style face="normal" font="default" size="100%">12</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>